Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$679K Sell
18,368
-40,950
-69% -$1.8M 0.34% 56
2026
Q1
$2.79M Sell
59,318
-2,639
-4% -$103K 1.66% 23
2025
Q4
$2.15M Buy
61,957
+3,135
+5% +$110K 1.29% 29
2025
Q3
$2.03M Buy
58,822
+589
+1% +$19.7K 1.83% 22
2025
Q2
$1.74M Buy
58,233
+3,792
+7% +$111K 1.79% 23
2025
Q1
$1.53M Buy
54,441
+6,156
+13% +$201K 1.34% 31
2024
Q4
$1.43M Buy
+48,285
New +$1.45M 1.29% 24

Other funds holding BP

SharpePoint's BP Position: Q2 2026 in Review

SharpePoint reduced its BP (BP) stake by 69% in Q2 2026, selling an estimated $1.8M and leaving 18,368 shares worth $679K. The position accounts for 0.34% of the portfolio, ranked #56.

SharpePoint first reported a position in BP in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.79M in Q1 2026. 1,166 funds tracked by Wall St. Rank hold BP as of Q2 2026.

  • SharpePoint held 18,368 shares of BP worth $679K as of Q2 2026.
  • SharpePoint sold 40,950 BP shares in Q2 2026, an estimated $1.8M.
  • BP made up 0.34% of SharpePoint's portfolio in Q2 2026, its #56 holding.
  • SharpePoint first reported a position in BP in Q4 2024 and has held it in 7 quarters since.
  • SharpePoint's BP position peaked at $2.79M in Q1 2026.
  • 1,166 funds tracked by Wall St. Rank held BP as of Q2 2026.

Based on SharpePoint's 13F filing for Q2 2026, filed 29 Jul 2026.